Clinical Trial of an Anti-cancer Drug, CA-4948 (Emavusertib), in Combination With Chemotherapy Treatment (FOLFOX Plus Bevacizumab) in Metastatic Colorectal Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Seagen Inc.
Eli Lilly and Company
Pfizer
Astellas Pharma Inc
Arcus Biosciences, Inc.
Pfizer
AstraZeneca
University of Miami
Novartis
City of Hope Medical Center
GlaxoSmithKline
Pfizer
Mayo Clinic
Enliven Therapeutics
Massachusetts General Hospital
Jonsson Comprehensive Cancer Center
M.D. Anderson Cancer Center
University of Alabama at Birmingham
Toray Industries, Inc
Jiangsu Hansoh Pharmaceutical Co., Ltd.
IGM Biosciences, Inc.
Memorial Sloan Kettering Cancer Center
Hansoh BioMedical R&D Company
Ohio State University Comprehensive Cancer Center
Ono Pharmaceutical Co. Ltd
Ohio State University Comprehensive Cancer Center
Merck Sharp & Dohme LLC
Ono Pharmaceutical Co. Ltd
National Cancer Institute (NCI)
Ono Pharmaceutical Co. Ltd
Ono Pharmaceutical Co. Ltd
National Cancer Institute (NCI)
OHSU Knight Cancer Institute
Sumitomo Pharma America, Inc.
University of Nebraska
Canadian Cancer Trials Group
University of Chicago
Barbara Ann Karmanos Cancer Institute
Ludwig Institute for Cancer Research
Sumitomo Pharma Co., Ltd.
GSO Global Clinical Research BV
Virginia Commonwealth University
Benaroya Research Institute
Gilead Sciences
University of Chicago
Eli Lilly and Company
TG Therapeutics, Inc.
M.D. Anderson Cancer Center
Eli Lilly and Company